EYE/EAR DROPS

August 15, 2026 by Pharmaguidances

EYE/EAR DROPS

S.no	GENERIC NAME	COMPOSTION	REF .	CLAIM	STRENGTH
1.	Atropine Sulphate Ophthalmic Solution IP	Composition:
		Atropine Sulphate	IP	1%,	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
2.	Atropine sulphate ophthalmic solution IP	Composition:
		Atropine sulphate	IP	0.01%&0.05%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	v/v
		Sterile Aqueous Base		q.s
3.	Amikacin Sulphate (1%) &(0.3%) HPMC Ophthalmic Solution	Composition:
		Amikacin Sulphate Eq. to Amikacin	IP	1%&0.3%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025 %	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
4.	Alcaftadine Ophthalmic Solution	Composition:
		Alcaftadine		0.25%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
5.	Amikacin Sulphate (1%)&(0.3%) Dexamethasone & HPMC Ophthalmic Solution	Composition:
		Amikacin Sulphate Eq. to Amikacin	IP	1%&0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025 %	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
6.	Azithromycin & Dexamethasone Eye /Ear Drops	Composition:
		Azithromycin	IP	10.0	mg
		Dexamethasone SodiumPhosphate	IP	1.0	mg
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	w/v
		Sterile suspension Base		q.s
7.	Azelastine hcl eye drop	Composition:
		Azelastine HCL	IP	0.05%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
8.	Bromfenac	Composition:

	Ophthalmic Solution	Bromfenac Sodium Eq. to Bromfenac		0.09%	w/v
		Benzalkonium chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
9.	Bimatoprost Ophthalmic Solution	Composition :
		Bimatoprost		0.01%&0.03%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
10.	Bimatoprost& Timolol Maleate Ophthalmic Solution	Composition :
		Bimatoprost		0.03%&0.01%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
11.	Brimonidine Tartrate Eye drop IP	Composition :
		Brimonidine Tartrate	IP	0.2%&0.10%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	v/v
		Sterile Aqueous Base		q.s
12.	Brimonidine Tartrate Eye drop IP	Composition :
		Brimonidine Tartrate	IP	0.15%	w/v
		Stabilised Oxychloro Complex (As Preservative)		0.005%	w/v
		Sterile Aqueous Base		q.s
13.	Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution	Composition :
		Brimonidine Tartrate	IP	0. 2%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	w/v
		Sterile Aqueous Base		q.s
14.	Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution	Composition :
		Brimonidine Tartrate	IP	0. 2%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	w/v
		Sterile Aqueous Base		q.s
15.	Brinzolamide eye Drops IP	Composition :
15.	Brinzolamide eye Drops IP	Brinzolamide (Sterile &Miicronized)	IP	1.0%	w/v

		Benzalkonium Chloride (As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
16.	Brinzolamide & Brimonidine Tartrate eye Drops	Composition :
		Brinzolamide (Sterile &Miicronized)	IP	1.0%	w/v
		Brimonidine Tartrate	IP	0. 2%	w/v
		Benzalkonium Chloride (As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
17.	Boric Acid, Zinc Sulphate & Sodium Borate Ophthalmic Solution	Composition:
		Boric Acid	IP	2%	w/v
		Zinc Sulphate	IP	0.1%	w/v
		Sodium Borate	IP	0.5%	w/v
		Chlorbutol (As Preservative)	IP	0.5%	w/v
		Glycerin	IP	2%	w/v
18.	Boric Acid, Borax Zinc Sulphate & Menthol Ophthalmic Solution	Composition:
		Boric Acid	IP	2%	w/v
		Borax	IP	0.2%	w/v
		Menthol	IP	0.005%	w/v
		Zinc Sulphate	IP	0.12%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		Q.S.
19.	Betamethasone & Neomycin Eye/ Ear Drops	Composition :
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Neomycin Sulphate	IP	0.5%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
20.	Betamethasone & Chloramphenicol Eye/ Ear Drops	Composition:
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Chloramphenicol	IP	0.5%	w/v
		Chloramphenicol	IP	0.5%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
21.	Betaxolol Eye drops IP	Composition :
		Betaxolol Hydrochloride Eq. to Betaxolol	IP	0.25%&0.5%&1.0 %	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
22.	Bepotastine	Composition :

	Ophthalmic Solution	Bepotastine		1.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
23.	Bepotastine Besilate Eye Drops	Composition :
		Bepotastine Besilate Eq. to Bepotastine	IP	15 10.70	mg mg
		Benzalkonium Chloride (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
24.	Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%)	Composition :
		Carboxymethyl Cellulose Sodium	IP	0.5%&1.0%	w/v
		Sodium Perborate (As Preservative)	BP	0.005%	w/v
		Sterile Aqueous Base		q.s
25.	Carboxymethyl Cellulose Sodium Eye drops IP (0.5%)&(1.0%)	Composition :
		Carboxymethyl Cellulose Sodium	IP	0.5%&1.0%	w/v
		Stabilised Oxychloro Complex (As Preservative)		0.005%	w/v
		Sterile Aqueous Base		q.s
26.	Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%)	Composition :
		Carboxymethyl Cellulose Sodium	IP	0.5%&1.0%	w/v
		Sterile Aqueous Base		q.s
27.	Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%) (With Glycerin)	Composition :
		Carboxymethyl Cellulose Sodium	IP	0.5%&1.0%	w/v
		Glycerin	IP	2%	w/v
		Sterile Aqueous Base		q.s
28.	Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%) (With Glycerin)	Composition :
		Carboxymethyl Cellulose Sodium	IP	0.5%&1.0%	w/v
		Glycerin	IP	2%	w/v
		Sterile Aqueous Base		q.s
29.	Carboxymethyl cellulose sodium with glycerin lubricant eye ointment	Composition:
		Carboxymethylcellulose sodium	IP	0.3%	w/v
		Glycerin	IP	1%	w/v
		Benzyl Alcohol (As Preservative)	IP	0.1%	v/v
		Sterile Ointment base		qs
30.	Sodium CarboxymethylCellulo se & N-Acetyl-	Composition
30.	Sodium CarboxymethylCellulo se & N-Acetyl-	Sodium Carboxymethyl Cellulose	IP	0.3%	w/v

	Carnosine Opthalmic Solution	N-Acetyl-Carnosine		1%	w/v
		Glycerin	IP	1%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	w/v
		Sterile aqueous vehicle		q.s
31.	Sodium Carboxymethyl Cellulose & N-Acetyl-Carnosine Opthalmic Solution	Composition:
		Sodium Carboxymethyl Cellulose	IP	0.3%	w/v
		N-Acetyl-Carnosine		0.1%	w/v
		Glycerin	IP	0.1%	w/v
		Boric Acid	IP	0.3%	w/v
		StabilisedOxychloro Complex(As Preservative)		0.005%	w/v
		Sterile aqueous vehicle		q.s
32.	Chloramphenicol Eye Drops IP	Composition :
		Chloramphenicol	IP	0.5%&1%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
33.	Chloramphenicol &HPMC Ophthalmic Solution	Composition :
		Chloramphenicol	IP	0.5%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
34.	Chloramphenicol, Dexamethasone &HPMC Eye/Ear Drops	Composition :
		Chloramphenicol	IP	1%	w/v
		Dexamethasone SodiumPhosphate	IP	0.01%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
35.	Chloramphenicol & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Composition :
		Chloramphenicol	IP	0.5%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
36.	Chlorpheniramine Maleate, Phenylephrine HCl & HPMC Eye/Ear drops	Composition:
		Chlorpheniramine Maleate	IP	0.2%	w/v
		Phenylephrine Hydrochloride	IP	0.12%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.02%	w/v
		Phenylmercuric Nitrate (As Preservative)	IP	0.001%	w/v

		Sterile Aqueous Base		q.s
37.	Ciprofloxacin Eye drops IP	Composition :
		Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin	IP	0.3%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
38.	Ciprofloxacin & HPMC Eye/ Ear drops	Composition :
		Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin	IP	0.3%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
39.	Ciprofloxacin & Dexamethasone Sodium Phosphate Eye/Ear drops	Composition :
		Ciprofloxacin HCL Eq. to Ciprofloxacin	IP	0. 3%	w/v
		Dexamethasone SodiumPhosphate Eq.to Dexamethasone phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
40.	Ciprofloxacin & Dexamethasone Sodium Phosphate & HPMC Eye/Ear drops	Composition :
		Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin	IP	0. 3%	w/v
		Dexamethasone SodiumPhosphate	IP	0.01%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
41.	Cyclopentolate Eye drops IP	Composition:
		Cyclopentolate Hydrochloride	IP	1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
42.	Cromolyn Sodium Opthalmic Solution USP	Composition:
		Sodium Cromoglycate	USP	2 %& 4%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
43.	Cyclosporine	Composition :

	Eye drops	Cyclosporine	IP	1.0&2.0&0.5	mg
		Benzalkonium Chloride (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
44.	Diclofenac Sodium Ophthalmic Solution	Composition :
		Diclofenac Sodium	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
45.	Dorzolamide Eye drops IP	Composition :
		Dorzolamide Hydrochloride Eq. to Dorzolamide	IP	2.0%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
46.	Dorzolamide and Timolol Eye Drops IP	Composition :
		Dorzolamide Hcl Eq.to Dorzolamide	IP	2%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
47.	Dexamethasone Sodium Phosphate Eye Drops USP	Composition :
		Dexamethasone Sodium Phosphate	IP	0.01%&0.1%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
48.	Dexamethasone & Neomycin Sulphate & HPMC Eye/Ear drops	Composition :
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Neomycin Sulphate	IP	0.5%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
49.	Dexamethasone Sodium Phosphate, Neomycin Sulphate, Boric Acid with Ophthalmic Solution	Composition :
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Neomycin Sulphate	IP	0.5%	w/v
		Boric acid	IP	1.2%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
50.		Composition:

	Sodium Phosphate, Neomycin Sulphate, Boric Acid with HPMC Ophthalmic Solution	Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Neomycin Sulphate	IP	0.5%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Boric Acid	IP	1.2%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
51.	Difluprednate Ophthalmic Suspension	Composition :
		Difluprednate		0.05%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile suspension Base		q.s
52.	Epinastine Eye drops IP	Composition :
		Epinastine Hydrochloride	IP	0.05%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Aqueous base		q.s
53.	Fluorometholone Eye Drops IP	Composition:
		Fluorometholone	IP	0.1%&0.25%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
54.	Fluorometholone& Chloramphenicol Ophthalmic Suspension	Composition:
		Fluorometholone	IP	0.1%	w/v
		Chloramphenicol	IP	1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
55.	Fluorometholone& Gatifloxacin Eye/Ear Drops	Composition:
		Fluorometholone	IP	0.1%	w/v
		Gatifloxacin (As Anhydrous)	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
56.	Flurbiprofen Sodium Eye Drops IP	Composition :
		Flurbiprofen Sodium	IP	0.03%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
57.	Flurbiprofen Sodium & HPMC Ophthalmic Solution	Composition :
		Flurbiprofen Sodium	IP	0.03%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v

		Sterile Aqueous Base		q.s
58.	Flurbiprofen Sodium & Chloramphenicol Ophthalmic Solution	Composition:
		Flurbiprofen Sodium	IP	0.03%	w/v
		Chloramphenicol	IP	0.5%	w/v
		Phenylmercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
59.	Fluconazole Eye /Ear Drops	Composition :
		Fluconazole	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
60.	Gatifloxacin Ophthalmic Solution	Composition:
		Gatifloxacin (As Anhydrous)	IP	0. 3%& 0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
61.	Gatifloxacin& HPMC Ophthalmic Solution	Composition :
		Gatifloxacin (As Anhydrous)	IP	0. 3%&0. 5%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
62.	Gatifloxacin& Ketorolac Tromethamine Ophthalmic Solution	Composition :
		Gatifloxacin Eq. to Anhydrous Gatifloxacin	IP	0.3%	w/v
		Ketorolac Tromethamine	IP	0.4%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
63.	Gatifloxacin& Flurbiprofen Ophthalmic Solution	Composition :
		Gatifloxacin (As Anhydrous)	IP	0.3%	w/v
		Flurbiprofen sodium	IP	0.03%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.001%	w/v
		Sterile Aqueous Base		q.s
64.	Gatifloxacin, Flurbiprofen &HPMC Ophthalmic Solution	Composition :
		Gatifloxacin (As Anhydrous)	IP	0.3%	w/v
		Flurbiprofen Sodium	IP	0.03%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v

		Sterile Aqueous Base		q.s
65.	Gatifloxacin& Dexamethasone Eye/Ear drops	Composition:
		Gatifloxacin (As Anhydrous)	IP	0. 3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
66.	Gatifloxacin& Prednisolone Acetate Ophthalmic Solution	Composition:
		Gatifloxacin (As Anhydrous)	IP	0. 3%	w/v
		Prednisolone Acetate	IP	1.0%	w/v
		Benzalkonium Chloride Solution(As preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
67.	Gatifloxacin& Betamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Composition :
		Gatifloxacin (As Anhydrous)	IP	0. 3%	w/v
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
68.	Gentamicin Sulphate Eye drops IP	Composition :
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
69.	Gentamicin Sulphate & HPMC Eye/Ear drops	Composition :
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
70	Gentamicin & Betamethasone Eye/Ear Drops	Composition :
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
71.	Gentamicin &	Composition :

	Betamethasone Ophthalmic Solution	Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Betamethasone SodiumPhosphate Eq. toBetamethasone	IP	0.01%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
72.	Gentamicin, Dexamethasone& Boric Acid Ophthalmic Solutio	Composition:
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.01%	w/v
		Boric Acid	IP	1.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
73.	Gentamicin,& Dexamethasone Ophthalmic Solution	Composition:
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s	v/v
74.	Gentamicin , Dexamethasone & HPMC Eye/Ear drops	Composition :
		Gentamicin Sulphate Eq. to Gentamicin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.01%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
75.	Glycerin & CMC Ophthalmic Solution	Composition:
		Glycerin	IP	1.0 %	w/v
		CMC	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
76.	Homatropine Hydrobromide Eye Drops IP (1%)&(2%)	Composition :
		Homatropine Hydrobromide	IP	1%&2%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
77.	Hydroxypropyl	Composition:

	methyl Cellulose Ophthalmic Solution USP	Hydroxypropylmethyl Cellulose	IP	0.3%	w/v
		StabilisedOxychloro Complex (As Preservative)		0.005%	w/v
		Sterile Aqueous Base		q.s
78.	Hydroxypropyl methyl Cellulose Ophthalmic Solution USP& Hypromellose (HPMC),	Composition:
		Hydroxypropylmethyl Cellulose	IP	0.3%	w/v
		Sodium Perborate (As Preservative)	BP	0.005%	w/v
		Sterile Aqueous Base		q.s
79.	Hydroxypropyl methyl Cellulose Ophthalmic Solution USP	Composition:
		Hydroxypropylmethyl Cellulose	IP	0.7%	w/v
		Sodium Perborate (As Preservative)	BP	0.005%	w/v
		Sterile Aqueous Base		q.s
80.	Hydroxypropyl methyl Cellulose , Glycerin & Dextran 70 Ophthalmic Solution	Composition:
		Hydroxypropylmethyl Cellulose	IP	0.3 %	w/v
		Glycerin	IP	0.2%	w/v
		Dextran 70	USP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
81.	HPMC, Borax, Boric Acid, Sodium chloride, & Potassium chloride Ophthalmic Solution	Composition:
		Hydroxypropylmethyl Cellulose	IP	2%	w/v
		Borax	IP	0.19%	w/v
		Boric Acid	IP	0.19%	w/v
		Sodium chloride	IP	0.45%	w/v
		Potassium chloride	IP	0.37%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
82.	HPMC, Borax, Boric Acid, Sodium chloride, & Potassium chloride Ophthalmic Solution (Hydroxypropyl methyl Cellulose Ophthalmic Solution)	Composition:
		Hydroxypropylmethyl Cellulose	IP	0.7%	w/v
		Borax	IP	0.19%	w/v
		Boric Acid	IP	0.19%	w/v
		Sodium chloride	IP	0.45%	w/v
		Potassium chloride	IP	0.37%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
83.	Itraconazole Ophthalmic	Composition :
83.	Itraconazole Ophthalmic	Itraconazole	IP	1%	w/v

	Suspension	Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
	Suspension	Sterile Suspension Base		q.s
84.	Ketorolac Tromethamine ophthalmic Solution	Composition :
		Ketorolac Tromethamine	IP	0.4%&0.5%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
85.	Ketorolac Tromethamine &HPMC Ophthalmic Solution	Composition :
		Ketorolac Tromethamine	IP	0.5%&0.4%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
86.	Ketorolac Tromethamine & Dexamethasone Ophthalmic Solution	Composition :
		Ketorolac Tromethamine	IP	0.5%	w/v
		Dexamethasone Sodium Phosphate Eq.to Dexamethasone phosphate	IP	0.01%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
87.	Ketorolac Tromethamine, Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Composition :
		Ketorolac Tromethamine	IP	0.5%	w/v
		Dexamethasone Sodium Phosphate	IP	0.01%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
88.	Ketorolac Tromethamine &Olopatadine Ophthalmic Solution	Composition :
		Ketorolac Tromethamine	IP	0.4%	w/v
		Olopatadine Hcl eq. to Olopatadine	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.05%	v/v
		Sterile Aqueous Base		q.s
89.	Levofloxacin Ophthalmic Solution	Composition:
89.	Levofloxacin Ophthalmic Solution	Levofloxacin Hemihydrate eq.to Levofloxacin	IP	0.5%&1.5%	w/v

	(0.5%)&(1.5%)	Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
	(0.5%)&(1.5%)	Sterile Aqueous Base		q.s
90.	Levofloxacin (0.5%) & HPMC Ophthalmic Solution	Composition:
		Levofloxacin Hemihydrate eq.to Levofloxacin	IP	0.5%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
91.	Loteprednol Etabonate Ophthalmic Suspension (0.2%)&(0.5%)	Composition :
		Loteprednol Etabonate		0.2%&0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Suspension Base		q.s
92.	Loteprednol Etabonate & Tobramycin Ophthalmic Suspension	Composition:
		Loteprednol Etabonate		0.5%	w/v
		Tobramycin Sulphate Eq.to Tobramycin	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Suspension Base		q.s
93.	Latanoprost Ophthalmic Solution USP	Each ml Contain:
		Latanoprost	USP	50	mcg
		Benzalkonium Chloride Solution(As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
94.	Latanoprost & Timolol Maleate Ophthalmic Solution USP	Each ml Contain:
		Latanoprost	USP	0.005%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
95.	Lomefloxacin eye drop	Composition :
		Lomefloxacin HCl		0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
96.	Moxifloxacin Eye drop IP	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Sterile Aqueous Base		q.s
97.	Moxifloxacin Eye drops IP	Composition:
97.	Moxifloxacin Eye drops IP	Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v

		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
98.	Moxifloxacin & HPMC Ophthalmic Solution	Composition :
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
99.	Moxifloxacin &Ketorolac Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Ketorolac Tromethamine	IP	0.5%& 0.4%	w/v
		Sterile Aqueous Base		q.s
100.	Moxifloxacin, Ketorolac &HPMC Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Ketorolac Tromethamine	IP	0. 4%&0. 5%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
101.	Moxifloxacin, Prednisolone Acetate Ophthalmic Suspension	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Prednisolone Acetate	IP	1.0%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
102.	Moxifloxacin, Prednisolone &HPMC Ophthalmic Suspension	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Prednisolone Acetate	IP	1.0%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
103.	Moxifloxacin, Dexamethasone ophthalmic Solution	Composition:
103.	Moxifloxacin, Dexamethasone ophthalmic Solution	Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v

		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Sterile Aqueous Base		q.s
104.	Moxifloxacin, Dexamethasone ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
105.	Moxifloxacin, Dexamethasone Eye / Ear dro	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
106.	Moxifloxacin, Dexamethasone& HPMC Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Dexamethasone Sodium Phosphate	IP	0. 1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
107.	Moxifloxacin, Betamethasone Eye / Ear drops	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Betamethasone sodium Phosphate	IP	0. 1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
108.	Moxifloxacin, Betamethasone& HPMC Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Betamethasone sodium Phosphate	IP	0. 1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
109.	Moxifloxacin&	Composition :

	Difluprednate Ophthalmic Solution	Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Difluprednate		0.05%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
110.	Moxifloxacin &Bromfenac Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Bromfenac Sodium Eq. toBromfenac		0.09%	w/v
		Benzalkonium chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
111.	Moxifloxacin HCL & Loteprednol Etabonate Ophthalmic Suspension	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0.5%	w/v
		Loteprednol Etabonate		0.5%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.01%	w/v
		Sterile Aqueous Vehicle		q.s
112.	Moxifloxacin & Tobramycin Ophthalmic Solution	Composition:
		Moxifloxacin Hydrochloride eq. to Moxifloxacin	IP	0. 5%	w/v
		Tobramycin Sulphate Eq.to Tobramycin	IP	0.3%	w/v
		Benzalkonium chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
113.	Natamycin Ophthalmic Suspension IP	Composition :
		Natamycin	IP	5%&2%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
114.	Nepafenac Ophthalmic Suspension IP	Composition:
		Nepafenac	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s.
115.	Norfloxacin Eye Drops IP	Composition :
		Norfloxacin	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
116.	Norfloxacin & HPMC Ophthalmic Solution	Composition :
		Norfloxacin	IP	0.3%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v

		Sterile Aqueous Base		q.s
117.	Norfloxacin, Betamethasone &HPMC Eye /Ear drops	Composition:
		Norfloxacin	IP	0.3%	w/v
		Betamethasone Sodium Phosphate	IP	0.01%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
118.	Norfloxacin & Dexamethasone Sodium Phosphate & HPMC ophthalmic Solution	Composition :
		Norfloxacin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.01%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
119.	Naphazoline , Chlorpheniramine Maleate, Zinc Sulphate, Menthol & Camphor Eye drops	Composition:
		Naphazoline Hydrochloride	USP	0.056 %	w/v
		Chlorpheniramine Maleate	IP	0.01%	w/v
		Zinc Sulphate	IP	0.12%	w/v
		Menthol	IP	0.0025%	w/v
		Camphor	USP	0.0025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
120.	Naphazoline Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Eye drops	Composition:
		Naphazoline Hydrochloride	USP	0.056 %	w/v
		Chlorpheniramine Maleate	IP	0.2%	w/v
		Phenylephrine Hydrochloride	IP	0.12%	w/v
		Methyl Para Hydroxy Benzoate(As Preservative)	IP	0.1%	w/v
		Sterile Aqueous Base		q.s
121.	Naphazoline, HPMC Zinc Sulphate, Boric Acid, Sodium Chloride, Ophthalmic Solution	Composition:
		Naphazoline Hydrochloride	USP	0.056 %	w/v
		Zinc Sulphate	IP	0.12%	w/v
		Boric Acid	IP	1.25%	w/v
		Hydroxypropyl methylcellulose	IP	0.025%	w/v
		Sodium Chloride	IP	0.05%	w/v
		Chlorbutol(As Preservative)	IP	0.35%	w/v
122.	Naphazoline Hydrochloride & HPMC Ophthalmic Solution	Composition :
		Naphazoline Hydrochloride	USP	0.056 %	w/v
		Hydroxypropylmethyl cellulose	IP	0.006 %	w/v
		Sterile Aqueous Base	q.s.

123.	Ofloxacin Ophthalmic Solution IP	Composition :
		Ofloxacin	IP	0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
124.	Ofloxacin with HPMC Eye/Ear drops	Composition :
		Ofloxacin	IP	0.3%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
125.	Ofloxacin & Dexamethasone Eye/Ear drops	Composition:
		Ofloxacin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate eq.to Dexamethasone Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
126. .	Ofloxacin & Dexamethasone with HPMC Eye/Ear drops	Composition:
		Ofloxacin	IP	0.3%	w/v
		Dexamethasone SodiumPhosphate	IP	0.1%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
127.	Ofloxacin with Betamethasone ophthalmic Solution	Composition:
		Ofloxacin	IP	0.3%	w/v
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
128.	Ofloxacin, Betamethasone with HPMC Eye/Ear drops	Composition:
		Ofloxacin	IP	0.3%	w/v
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
129.	Ofloxacin & Ketorolac Tromethamine	Composition:
		Ofloxacin	IP	0.3%	w/v
		Ketorolac Tromethamine	IP	0.5%	w/v

	Ophthalmic Solution	Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
	Ophthalmic Solution	Sterile Aqueous Base		q.s
130.	Ofloxacin, Ketorolac Tromethamine & HPMC Ophthalmic Solution	Composition :
		Ofloxacin	IP	0.3%	w/v
		Ketorolac Tromethamine	IP	0.5%	w/v
		HydroxypropylmethylCellu lose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
131.	Ofloxacin &Prednisolone Ophthalmic Suspension	Composition:
		Ofloxacin	IP	0.3 %	w/v
		Prednisolone Acetate	IP	1.0%	w/v
		Benzalkonium Chloride Solution	IP	0.02 %	v/v
		Sterile suspension Base		q.s.
132.	Ofloxacin, Prednisolone & HPMC Ophthalmic Suspension	Composition:
		Ofloxacin	IP	0.3 %	w/v
		Prednisolone Acetate	IP	1.0%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02 %	v/v
		Sterile suspension Base		q.s.
133.	Olopatadine Ophthalmic Solution IP	Composition:
		OlopatadineHydrochloride Eq. to Olopatadine	IP	0.1%&0.2%	w/v
		Benzalkonium Chloride solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base	q.s
134.	Olopatadine with HPMC Ophthalmic Solution	Composition:
		OlopatadineHydrochloride Eq. to Olopatadine	IP	0.1%&0.2%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
135	Phenylephrine Hydrochloride Eye Dro	Composition:
		Phenylephrine Hydrochloride	IP	5%&10%&2.5%	w/v
		Benzalkonium Chloride (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
136.	Pilocarpine Hydrochloride Ophthalmic Solution USP	Composition :
		Pilocarpine Hydrochloride	USP	2%&4%	w/v
		Benzalkonium Chloride solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
137.	Pilocarpine Nitrate	Composition :

	Eye Drops IP (1%)	Pilocarpine Nitrate	IP	1%& 2%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
138.	Pilocarpine Nitrate & HPMC Eye Drops	Composition :
		Pilocarpine Nitrate	IP	1%&2%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025 %	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
139.	Proparacaine Ophthalmic SolutionUSP	Composition:
		Proparacaine Hydrochloride	USP	0.5 %	w/v
		Chlorbutol(As Preservative)	IP	0. 5%	w/v
		Sterile Aqueous Base		q.s
140.	Prednisolone Acetate Ophthalmic Suspension USP	Composition:
		Prednisolone Acetate	IP	1.0%	w/v
		Benzalkonium Chloride Solution	IP	0.02%	v/v
		Sterile Aqueous Base		q.s.
141.	Prednisolone Acetate & HPMC Ophthalmic Solution	Composition
		Prednisolone Acetate	IP	1.0%	w/v
		Hydroxypropyl methyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
142.	Povidone Iodine Ophthalmic Solution	Composition:
		Povidone Iodine (Available Iodine 0.5%)	IP	5%	w/v
		Benzalkonium Chloride Solution As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
143	Polymyxin B-Sulphate &Chloramphenicol Ophthalmic Solution	Each ml contain :
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	mg
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
144.	Polymyxin B-Sulphate, Chloramphenicol & HPMC Ophthalmic Solution	Each ml Contains:
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	mg
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v

		Sterile Aqueous Base		q.s.
145.	Polymyxin B-Sulphate, Chloramphenicol & Dexamethasone Sodium Phosphate Ophthalmic Solution	Each ml contains:
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	Mg
		Dexamethasone SodiumPhosphate Eq.to Dexamethsone phosphate	IP	0.1%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
146.	Polymyxin B-Sulphate, Chloramphenicol & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Each ml contains:
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	mg
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
147.	Polymyxin B-Sulphate, Chloramphenicol & Betamethasone Eye/Ear drops	Each ml contains:
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	Mg
		Betamethasone SodiumPhosphate	IP	0.1%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
148.	Polymyxin B-Sulphate, Chloramphenicol & Betamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Each ml Contains:
		Polymyxin B- Sulphate	BP	5000	IU
		Chloramphenicol	IP	10	mg
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
149.	Polyethylene Glycol & Propylene Glycol Ophthalmic Solution	Composition:
		Polyethylene Glycol 400	IP	0.4%	w/v
		Propylene Glycol	IP	0.3%	w/v
		Polyquad (Preservative)		0.001%	w/v
		Sterile Aqueous Base		q.s
150.	Polyethylene Glycol & Propylene Glycol Ophthalmic Solution	Composition:
		Polyethylene Glycol 400	IP	0.4%	w/v
		Propylene Glycol	IP	0.3%	w/v
		Stabilised Oxychloro Complex (As Preservative)	IP	0.005%	v/v

		Sterile Aqueous Base		q.s
151.	Potassium Iodide, Calcium Chloride & Sodium Chloride Ophthalmic Solution	Composition:
		Potassium Iodide	IP	3.3%	w/v
		Calcium Chloride (As Anhydrous)	IP	1%	w/v
		Sodium Chloride	IP	0.83%	w/v
		Methyl Paraben (As Preservative)	IP	0.023%	w/v
		Propyl Paraben (As Preservative)	IP	0.011%	w/v
		Sterile Aqueous Base		q.s
152.	Polyvinyl Alcohol & Povidone Ophthalmic Solution	Composition:
		Polyvinyl Alcohol	IP	1.4%	w/v
		Povidone	IP	0.6%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
153.	Sodium Chloride Ophthalmic Solution USP	Composition :
		Sodium Chloride	IP	0.9%&5%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
154.	Sodium Iodide & Mono basic Calcium Phosphate Eye /Ear drops	Composition:
		Sodium Iodide	IP	1%	w/v
		Mono basic Calcium Phosphate	IP	0.5%	w/v
		Chlorocresol (As Preservative)	IP	0.05%	w/v
		Sterile Aqueous Base		q.s
155.	Sodium Carboxymethyl Cellulose & N-Acetyl-Carnosine Opthalmic Solution	Each ml contains:
		Carboxymethyl Cellulose Sodium	IP	3	mg
		N-Acetyl-Carnosine		10	mg
		Glycerin	IP	10	mg
		Boric Acid	IP	3	mg
		Benzyl Alcohol (As Preservative)	IP	0.1%	v/v
		Sterile aqueous vehicle		q.s
156.	Sodium Hyaluronate Eye Drops (0.1%)	Composition :
		Sodium Hyaluronate	IP	0.1%	w/v
		Stabilised Oxychloro Complex (As Preservative)	IP	0.005%	v/v
		Sterile Aqueous Base		q.s
157.	Sodium Hyaluronate Eye Drops (0.1%)	Composition :
		Sodium Hyaluronate	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
158.	Sodium Hyaluronate	Composition :

	Eye Drops (0.15%)	Sodium Hyaluronate	IP	0.15%&0.18%	w/v
	Eye Drops (0.15%)	Sterile Aqueous Base		q.s
159.	Soframycin (franmycetin) eye drop	Composition :
		Soframycin (franmycetin)		0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.01%	v/v
		Sterile Aqueous Base		q.s
160.	Sulphacetamide (10%)&(20%)&(30%) Eye Drops IP	Composition :
		Sulphacetamide Sodium	IP	10%&20%&30%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
161.	Sulphacetamide Sodium &HPMC Ophthalmic Solution	Composition :
		Sulphacetamide Sodium	IP	20%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
162.	Sulphacetamide Sodium With Chloramphenicol Ophthalmic Solution	Composition :
		Sulphacetamide Sodium	IP	20%	w/v
		Chloramphenicol	IP	0.5%	w/v
		Benzalkonium Chloride solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
163.	Sulphacetamide Sodium & Chloramphenicol & HPMC Ophthalmic Solution	Composition :
		Sulphacetamide Sodium	IP	10%	w/v
		Chloramphenicol	IP	0.5%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Phenyl Mercuric Nitrate (As Preservative)	IP	0.002%	w/v
		Sterile Aqueous Base		q.s
164.	Sparfloxacin Ophthalmic Solution	Composition:
		Sparfloxacin		0.3%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
165.	Sparfloxacin& HPMC Ophthalmic Solution	Composition :
		Sparfloxacin		0.3%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
166.	Timolol Maleate Eye Drops IP	Composition :
		Timolol Maleate Eq. toTimolol	IP	0.25%&0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
167.	Timolol Maleate	Composition:

	&Polyvinyl Alcohol Eye Drops	Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		Polyvinyl Alcohol	IP	1.4%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
168.	Tropicamide Eye drops IP	Composition:
		Tropicamide	IP	1%	w/v
		Benzalkonium Chloride solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
169.	Tropicamide with Phenylephrine Hydrochloride Eye Drops	Composition:
		Tropicamide	IP	0.8%&1.0%	w/v
		Phenylephrine Hydrochloride	IP	5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		Q.S
170.	Tobramycin Ophthalmic Ointment USP	Each gm contains:
		Tobramycin Sulphate Eq. to Tobramycin	IP	0. 3%	w/w
		Benzalkonium chloride solution (As Preservative)	IP	0.01%&0.02%	v/w
		Sterilized Paraffin Base		q.s.
171.	Tobramycin Sulphate & HPMC Ophthalmic Solution	Composition :
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Hydroxypropylmethylcellul ose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
172.	Tobramycin Sulphate and Dexamethasone Sodium Phosphate Ophthalmic Solution	Composition :
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate Eq.to Dexamethasone phosphate	IP	0.1%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
173.	Tobramycin Sulfate & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution	Composition :
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Dexamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v

		Sterile Aqueous Base		q.s
174.	Tobramycin, Betamethasone &HPMC Ophthalmic Solution	Composition:
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Betamethasone Sodium Phosphate	IP	0.1%	w/v
		Hydroxypropylmethyl Cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s
175.	Tobramycin &Fluorometholone Ophthalmic Suspension	Composition:
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Fluorometholone	IP	0.1%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
176.	Tobramycin ,Fluorometholone& HPMC Ophthalmic Suspension	Composition:
		Tobramycin Sulphate Eq. to Tobramycin	IP	0.3%	w/v
		Fluorometholone	IP	0.1%	w/v
		Hydroxypropylmethyl cellulose	IP	0.025%	w/v
		Benzalkonium Chloride Solution(As Preservative)	IP	0.02%	v/v
		Sterile Suspension Base		q.s
177.	Tetrahydrozoline HCL Ophthalmic Solution USP	Composition:
		Tetrahydrozoline Hydrochloride	USP	0.05%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02%	v/v
		Sterile Aqueous Base		q.s.
178.	Travoprost Ophthalmic Solution IP	Composition:
		Travoprost	IP	40	mcg
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02 %	v/v
		Sterile suspension Base		q.s.
179.	Travoprost& Timolol Maleate Ophthalmic Solution IP	Composition:
		Travoprost	IP	0.004%	w/v
		Timolol Maleate Eq. to Timolol	IP	0.5%	w/v
		Benzalkonium Chloride Solution (As Preservative)	IP	0.02 %	v/v
		Sterile suspension Base		q.s.

For enquiries related to COPP , Manufacturing , Third-Party Manufacturing,PCD Pharma Franchise, and Pharmaceutical, Nutraceutical & Ayurvedic Products, our dedicated team is ready to assist you.

Whether you are looking for product quotations, business partnerships, third-party manufacturing opportunities, or product-related support, please feel free to get in touch with us.

Phone: +91 82647 25769
WhatsApp: +91 82647 25769
Email: [email protected]
Website: https://aasplifesciences.com/

We look forward to connecting with you, understanding your requirements, and building a long-term business partnership. Let us work together to create new opportunities and support your business growth.

AASP Lifesciences Pvt. Ltd. — Your Trusted Partner in Pharmaceutical & Healthcare Solutions.

Post Views: 10